{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:44:01Z","timestamp":1772523841889,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamaoncol.2019.0046","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T16:59:54Z","timestamp":1555606794000},"page":"906","source":"Crossref","is-referenced-by-count":102,"title":["Association of Anti\u2013Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma"],"prefix":"10.1001","volume":"5","author":[{"given":"Henry T.","family":"Quach","sequence":"first","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Dewan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin K.","family":"Ancell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"16","key":"cld190002r1","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jama.2018.13995","article-title":"Immune Checkpoint Inhibitor Toxicity in 2018.","volume":"320","author":"Johnson","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"cld190002r2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jamadermatol.2015.2707","article-title":"Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.","volume":"152","author":"Hua","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"7","key":"cld190002r3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1200\/JCO.2015.66.1389","article-title":"Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.","volume":"35","author":"Weber","year":"2017","journal-title":"J Clin Oncol"},{"issue":"18","key":"cld190002r4","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/cncr.31629","article-title":"High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma.","volume":"124","author":"Faje","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"cld190002r5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.det.2018.02.010","article-title":"Pruritus Associated with Targeted Anticancer Therapies and Their Management.","volume":"36","author":"Wu","year":"2018","journal-title":"Dermatol Clin"},{"issue":"Nov","key":"cld190002r6","first-page":"10","article-title":"Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo.","author":"Richmond","year":"2018","journal-title":"J Invest Dermatol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/6\/906\/17666971\/jamaoncology_quach_2019_ld_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T15:02:46Z","timestamp":1560438166000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2019.0046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.0046","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}